Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience

Ophthalmol Retina. 2022 Jul;6(7):638-641. doi: 10.1016/j.oret.2022.02.001. Epub 2022 Feb 7.

Abstract

In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19-positive patients.

Keywords: COVID-19; Lockdown; Practice patterns; Proliferative vitreoretinopathy; Rhegmatogenous retinal detachment.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / epidemiology
  • Communicable Disease Control
  • Humans
  • Retinal Detachment* / diagnosis
  • Retinal Detachment* / surgery
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity